IVC Filter Lawsuits Continue To Mount With Claims of Failure And Serious Injury

   

Court Records Indicate 339 IVC Filter Lawsuits Are Now Pending After Claims of Migration, Tilting, and Puncture the heart, Lungs or Inferior Vena Cava

ivc-filter-lawsuit-attorney-class-action-lawsuits-4IVC filter lawsuits involving devices manufactured by C.R. Bard, Inc. and Cook Medical, Inc. continue to grow in two multidistrict litigations now underway in federal court. According to an MDL Statistics Report issued by the U.S. Judicial Panel on Multidistrict Litigation on February 16, 2016, 84 product liability claims have been filed in the U.S. District Court, District of Arizona, on behalf of plaintiffs who were allegedly harmed by Bard’s G2 and Recovery retrievable IVC filters. (In Re: Bard IVC Filters Product Liability Litigation – MDL No. 2641)

There have been 255 IVC filter injury claims that put forth similar allegations in regards to Cook Medical’s Celect and Gunther Tulip products are pending in a second centralized proceeding that is moving forward in the U.S. District Court, Southern District of Indiana. (In Re: Cook Medical, Inc. IVC Filters Product Liability Litigation – MDL No. 2570)

IVC (inferior vena cava) filters are small, cage-like devices indicated for the prevention of pulmonary embolism. Doctors implant the blood clot filters into the inferior vena cava, where they capture clots that have broken loose before they can travel to the heart and lungs. The Celect, Gunther Tulip, G2 and Recovery IVC filters named in these lawsuits were designed for temporary placement, and are intended to be removed once a patient is no longer in danger of having a pulmonary embolism. The U.S. Food and Drug Administration (FDA) recently reminded doctors of the importance of timely IVC filter retrieval, as leaving the devices in place increases the risk of serious complications.
[fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm396377.htm, October 6, 2014]

C.R. Bard introduced the Recovery IVC filter in 2003. After making slight alternations to its design, the device was renamed the G2 and relaunched just two years later. A 2010 study published in the Archives of Internal Medicine suggested the Bard Recovery filter failure rate was 25%, while the Bard G2 filter failure rate was around 12%. Last year, NBC News aired a series of investigative reports that suggested C.R. Bard was aware of serious problems associated with the G2 and Recovery filters, but failed to recall the products or issue warnings to doctors.
[archinte.jamanetwork.com/article.aspx?articleid=226212, JAMA Internal Medicine]
[nbcnews.com/health/health-news/did-blood-clot-filter-used-thousands-americans-have-fatal-flaw-n384536, NBC News]
[nbcnews.com/health/health-news/why-did-firm-keep-selling-problem-blood-clot-filters-n488166, NBC News]

Cook Medical’s Celect and Gunther Tulip line of blood clot filters have also raised similar concerns. Research published in 2012 in CardioVascular and Interventional Radiology suggested that these devices showed some degree of vena cava perforation after just 71 days. Full perforation of at least one component all the way through the inferior vena cava wall was observed in 86% of the cases. The filters were found to have tilted in 40% of cases.
[ncbi.nlm.nih.gov/pubmed/21448771, CardioVascular and Interventional Radiology, April 2012]
Plaintiffs who have filed Cook or Bard IVC filter lawsuits claim that the blood clot filters named in their complaints suffer from high rates of fracture, tilting and migration, all of which can lead to serious complications, including:

• Perforated heart
• Perforated lungs
• Hemorrhagic pericardial effusion (a buildup of blood around the heart)
• Cardiac tamponade (disruption of the heart caused by excess fluid)
• Ventricular tachycardia (accelerated heart beat)
• Puncturing or perforation of the inferior vena cava

They further allege that Cook and Bard were aware of these risks, and failed to provide adequate warnings to doctor and patients.

About Southern Med Law and Filing an IVC Filter Lawsuit: Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective advocate for those who were harmed due to negligent medical device manufacturers. If you or a loved one were injured by a Bard retrievable IVC filter, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Bard IVC filter lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

Southern Med Law:
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525

Fax: 205-547-5526
francois@southernmedlaw.com
http://www.southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam

This entry was posted in Southern Med Law | Article. Bookmark the permalink.